Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP407137.RA08Sah8O7lcHyIfL2nxGzOIvcwDc0Z_xkCse5t3YJzFg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP407137.RA08Sah8O7lcHyIfL2nxGzOIvcwDc0Z_xkCse5t3YJzFg130_assertion type Assertion NP407137.RA08Sah8O7lcHyIfL2nxGzOIvcwDc0Z_xkCse5t3YJzFg130_head.
- NP407137.RA08Sah8O7lcHyIfL2nxGzOIvcwDc0Z_xkCse5t3YJzFg130_assertion description "[Allogeneic stem cell transplantation (allo-SCT) is a potentially curative therapy for chronic myeloid leukemia and Philadelphia chromosome-positive (Ph(+)) acute lymphoblastic leukemia, and the graft-vs-leukemia (GVL) effect can eradicate residual leukemia after allo-SCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407137.RA08Sah8O7lcHyIfL2nxGzOIvcwDc0Z_xkCse5t3YJzFg130_provenance.
- NP407137.RA08Sah8O7lcHyIfL2nxGzOIvcwDc0Z_xkCse5t3YJzFg130_assertion evidence source_evidence_literature NP407137.RA08Sah8O7lcHyIfL2nxGzOIvcwDc0Z_xkCse5t3YJzFg130_provenance.
- NP407137.RA08Sah8O7lcHyIfL2nxGzOIvcwDc0Z_xkCse5t3YJzFg130_assertion SIO_000772 22665066 NP407137.RA08Sah8O7lcHyIfL2nxGzOIvcwDc0Z_xkCse5t3YJzFg130_provenance.
- NP407137.RA08Sah8O7lcHyIfL2nxGzOIvcwDc0Z_xkCse5t3YJzFg130_assertion wasDerivedFrom befree-20150227 NP407137.RA08Sah8O7lcHyIfL2nxGzOIvcwDc0Z_xkCse5t3YJzFg130_provenance.
- NP407137.RA08Sah8O7lcHyIfL2nxGzOIvcwDc0Z_xkCse5t3YJzFg130_assertion wasGeneratedBy ECO_0000203 NP407137.RA08Sah8O7lcHyIfL2nxGzOIvcwDc0Z_xkCse5t3YJzFg130_provenance.